After accumulation, acceleration. Timing appears favorable to go long in shares of Arkema and to anticipate an exit of the trading range on the upside.
Summary
● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● The company presents an interesting fundamental situation from a short-term investment perspective.
● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● The company appears to be poorly valued given its net asset value.
● Given the positive cash flows generated by its business, the company's valuation level is an asset.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Weaknesses
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Arkema is one of the world's leaders in the development, manufacturing and marketing of chemical products. Net sales break down by family of products as follows:
- advanced materials (37.4%): high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, etc.;
- adhesives (28.5%): sealants, adhesives for floors and tiles, waterproofing products, etc.;
- coating solutions (25.3%): resins, emulsions for adhesives, surface coating products, absorbents, etc.;
- intermediate products (8.4%): thermoplastic polymers (PMMA), acrylic products, fluorinated gases, etc.;
- other (0.4%).
At the end of 2023, the group had 148 production sites worldwide.
Net sales are distributed geographically as follows: France (7.8%), Europe (26.6%), United States-Canada-Mexico (36.5%), China (11%), Asia (12.6%) and others (5.5% ).